Apologies ... A Medically Induced, but Temporary, Hiatus from Utah Money Watch
Apparently I came through the surgery with "Flying Colors," which is awesome!
Isn't modern medicine amazing?!?!?!
Utah's Top 17 Business News Nuggets from April 2024 that You Might have Missed
{AUTHOR'S NOTE: Clearly, not every news announcement deserves to be the top story of the day. Nevertheless, many news items are still significant and should be acknowledged as such. Hence, this write-up is designed to specifically focus on Utah's business "news nuggets" from the
OPINION: The Seven Most Intriguing Startups I Saw at Last Week's Investors Choice Conference
What were the seven most compelling and intriguing businesses that presented during last week's Investors Choice conference? I share my thoughts in this report.
This Week's $200 Million Investment that Few Utahns Know About has Changed Control of a Pioneering Utah Biotech Firm
Utah's market-leading Brain-Computer-Interface company, Salt Lake City-based Blackrock Neurotech, has sold controlling interest to Tether for a $200 million investment
In news that will shock most executives in Utah's business, life sciences, and technology communities, Salt Lake City-based Blackrock Neurotech has sold controlling interest in its
Kinect Capital Welcomes 23 Presenting Companies to this Week's Investor Choice Conference in Salt Lake City
"According to Kinect Capital, its data says that since 2009 Investors Choice alumni firms have raised over $1.2 billion in investment capital while also achieving financial exits of over $10 billion."
The Property of Five Utah Hospitals has Changed Hands in a Transaction that Values them at Just Under $1.2 Billion
A 75% ownership stake in the real estate of 1) Davis Hospital and Medical Center, 2) Jordan Valley Medical Center, 3) Jordan Valley Medical Center-West Valley Campus, 4) Mountain Point Medical Center, and 5) Salt Lake Regional Medical Center have been sold by Alabama's Medical Properties Trust to
The Underwriters of the PACS Group IPO have Exercised their Option to Purchase ~3.21 Million Shares of Common Stock from the Company's Co-Founders
Yesterday evening, Farmington, Utah-based PACS Group (NYSE:PACS) announced that the underwriters of the company's just completed initial public offering have exercised their 30-day option to purchase ~3.21 million shares of PACS common stock from the firm's co-founders at the offering price of $21.00/